Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
128 participants
OBSERVATIONAL
2016-07-31
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intestinal Microbial Dysbiosis in Chinese Infants With Short Bowel Syndrome With Different Complications
NCT02699320
Metronidazole Pharmacokinetics (PK) in Premature Infants
NCT01222585
The Motility Mother-Child Cohort
NCT05491161
Effects on Crying Time in Colicky Infants With the Supplementation of Lactobacillus Reuteri DSM 17938
NCT02574065
Use of Prokinetics in Early Enteral Feeding in Preterm Infants
NCT01569633
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* exclusively breastfed (at baseline)
* vaginal birth delivery mode
Exclusion Criteria
* Formula fed (at baseline)
* Diseases or lesions of the central nervous system, acute pediatric disease, developmental/neurologic/metabolic disorders, chronic medical conditions, or head injury
* Family history of narcolepsy/psychosis/bipolar disorder
* Conceptual age of \< 37 or \> 42 weeks
* Low birth weight (\< 2500g)
* Co-sleeping during \> 50% of the time in the same bed
* Medication use affecting sleep/alertness
* Vaccination (2 weeks prior to study)
* Antibiotics (3 months prior to study)
* Travelling across a time zone (within 1 month prior to study)
* intrauterine drug exposure, intrauterine infection, known or suspected drug or alcohol abuse
* Insufficient knowledge of German (parents)
2 Months
13 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Children's Hospital, Zurich
OTHER
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Salome Kurth, Dr. sc. nat.
Role: PRINCIPAL_INVESTIGATOR
Clinic for Pulmonology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-00730
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.